The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.
Please visit the COVID-19 & Cancer Resource Center where COVID-related content is freely available.
At the Crossroads: COVID-19 and Immune Checkpoint Blockade for Cancer, Chiara Garassino and Antoni Ribas.
Trending - Altmetric
- Targeted therapy given after anti-PD-1 leads to prolonged responses in mouse melanoma models through sustained antitumor immunityLast mentioned on Thu Mar 04 2021
- Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor EfficacyLast mentioned on Thu Feb 25 2021
- Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune ResistanceLast mentioned on Thu Feb 25 2021
- The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor ActivityLast mentioned on Fri Feb 05 2021
- pVACtools: a computational toolkit to identify and visualize cancer neoantigensLast mentioned on Wed Feb 17 2021
- See more
Advertisement